Evidence map›Paper›PMID 33206581›Full record

ArticleAutophagy2021

Enhanced viability and function of mesenchymal stromal cell spheroids is mediated

Shobha Regmi, Pawan Kumar Raut, Shiva Pathak, Prakash Shrestha, Pil-Hoon Park, Jee-Heon Jeong

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Study on theInternational journal of molecular medicine · 2025
    Article
  13. Article
  14. Article
  15. Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Shobha RegmiCollege of Pharmacy, Yeungnam University, Gyeongbuk, Gyeongsan, South Korea.
Pawan Kumar RautCollege of Pharmacy, Yeungnam University, Gyeongbuk, Gyeongsan, South Korea.
Shiva PathakCollege of Pharmacy, Yeungnam University, Gyeongbuk, Gyeongsan, South Korea.
Prakash ShresthaCollege of Pharmacy, Yeungnam University, Gyeongbuk, Gyeongsan, South Korea.
Pil-Hoon ParkCollege of Pharmacy, Yeungnam University, Gyeongbuk, Gyeongsan, South Korea.
Jee-Heon JeongCollege of Pharmacy, Yeungnam University, Gyeongbuk, Gyeongsan, South Korea.
Yeungnam University · KRStanford Medicine · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stromal cells (MSCs) have received attention as promising therapeutic agents for the treatment of various diseases. However, poor post-transplantation viability is a major hurdle in MSC-based therapy, despite encouraging results in many inflammatory disorders. Recently, three dimensional (3D)-cultured MSCs (MSC

Indexed as

AutophagyMesenchymal Stem CellsAnimalsHeme Oxygenase-1Hypoxia-Inducible Factor 1, alpha SubunitMembrane ProteinsMiceReactive Oxygen SpeciesHeme Oxygenase-1Hif1a protein, mouseHmox1 protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMembrane ProteinsReactive Oxygen Species3D cultureheme oxygenase 1hypoxia inducible factor 1 subunit alphaMSC survivaltransplantation

Identifiers

PMID33206581
PMCPMC8526044
OpenAlexW3101534978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.